NYSE Pre-Market Update: Trump Tariffs to Resume August 1, 2025 – Market Implications & Sector Analysis

The New York Stock Exchange (NYSE) issued a pre-market advisory on July 25, 2025, confirming that the Trump-era tariffs on $370 billion worth of Chinese imports will resume effective August 1, 2025. This policy reversal, announced by the U.S. Trade Representative (USTR), has triggered pre-market volatility, with S&P 500 futures down 1.2% and China-exposed stocks…

NYSE

Adani Group Submits Unconditional Bid for Jaiprakash Associates in 2025: Reshaping India’s Infrastructure Landscape

In a landmark move that could redefine India’s infrastructure and cement sectors, the Adani Group submitted an unconditional bid for debt-laden Jaiprakash Associates Limited (JAL) on March 15, 2025. This strategic acquisition, valued at ₹18,500 crore, represents one of the most significant resolutions under India’s Insolvency and Bankruptcy Code (IBC) framework. This comprehensive analysis covers:…

Adani

Mega IPOs Turn Into Mega Disasters: Can HDB Financial Break the ₹10,000 Crore Curse?

The Indian IPO market has witnessed a troubling trend—mega public offerings (IPOs) above ₹10,000 crore have repeatedly disappointed investors. From Paytm (2021) to LIC (2022), high-profile debuts have turned into long-term losses. Now, HDB Financial Services, the NBFC arm of HDFC Bank, is preparing for a ₹15,000 crore IPO in late 2025. This blog examines:…

IPO

Renowned Economist and Policy Researcher Radhika Pandey Passes Away at 46

The economic and policy research community is mourning the untimely demise of Radhika Pandey, a distinguished economist, policy researcher, and columnist associated with The Print. She passed away at the age of 46, leaving behind a legacy of insightful research, impactful policy contributions, and thought-provoking journalism. Early Life and Education Radhika Pandey was a highly…

Radhika Pandey

Globe Civil Projects IPO to Open on June 24: Fresh Issue of ₹150 Crore – Key Details, GMP, & Should You Invest?

Breaking News: Globe Civil Projects IPO Date Announced – 100% Fresh Issue, No OFS The much-anticipated Globe Civil Projects Limited IPO is set to open for subscription on June 24, 2025, with a pure fresh issue of ₹150 crore. The company, a leading civil construction and infrastructure firm, aims to utilize the proceeds for working…

IPO

Satellite Images Reveal “Unusual Activity” at Iran Nuclear Site: Experts Raise Alarms

Breaking: Suspicious Movements Detected at Iran’s Key Nuclear Facility Recent satellite imagery has uncovered “unusual activity” at Iran’s Fordow Fuel Enrichment Plant (FFEP), sparking concerns among global intelligence agencies and nuclear watchdogs. The images, analyzed by independent monitoring groups, suggest increased movements of vehicles, construction work, and possible uranium enrichment preparations—raising fears of accelerated nuclear…

Iran

SEBI Bars Sanjiv Bhasin and 11 Others for Alleged Stock Manipulation: Key Details & Market Impact

Introduction The Securities and Exchange Board of India (SEBI) has taken strict action against Sanjiv Bhasin, a well-known market expert, and 11 other entities for their alleged involvement in stock price manipulation. The regulatory body has imposed a trading ban and monetary penalties, sending shockwaves through the Indian financial markets. This blog covers: ✔ Who…

SEBI

American Express Plans ‘Largest Investment Ever’ in Platinum Credit Card: What to Expect?

Introduction American Express (Amex), a global leader in premium financial services, has announced its biggest-ever investment in the Platinum Credit Card segment. This strategic move aims to enhance rewards, benefits, and exclusivity for high-net-worth customers, reinforcing its position against rivals like Chase Sapphire Reserve and Capital One Venture X. In this blog, we explore: Why…

American Express

Sun Pharma Begins Succession Plan: Sudhir V. Ganorkar Succeeds Dilip Shanghvi as Managing Director

Introduction In a significant leadership transition, Sun Pharmaceutical Industries Ltd., India’s largest pharmaceutical company, has announced Sudhir V. Ganorkar as its new Managing Director (MD), succeeding founder Dilip Shanghvi. This strategic move marks a pivotal shift in Sun Pharma’s leadership as it prepares for the next phase of growth in the global pharmaceutical market. This…

Sun Pharma